France to Reimburse Obesity Treatments Wegovy and Mounjaro for Severe Cases Starting Mid-June
France will begin reimbursing 65% of the cost for obesity treatments Wegovy and Mounjaro starting mid-June, according to official decrees. The reimbursements are strictly controlled and limited to patients with severe obesity, potentially costing the national health insurance around €100 million annually.



